Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nutt

Showing results (61-70 of 179) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|March 27, 2007
Development of a rational scale to assess the harm of drugs of potential misuseDavid Nutt, Leslie A King, William Saulsbury, et al.
BMJ (Clinical Research Ed.)|October 16, 2024
Should recreational cannabis be legalised in the UK?David Nutt, Lucy Stafford, Robin M Murray, et al.
The European Journal of Neuroscience|June 7, 2016
Introduction to the 2016 Consensus Document on European Brain ResearchMonica Di Luca, Paul Bolam, John Foxe, et al.
Journal of Psychopharmacology (Oxford, England)|January 25, 2013
Generic legislation of new psychoactive drugsJan van Amsterdam, David Nutt, Wim van den Brink
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 22, 2016
Neurochemical binding profiles of novel indole and benzofuran MDMA analoguesJakob A Shimshoni, Ilan Winkler, Ezekiel Golan, et al.
Scientific Reports|July 26, 2023
The difference between 'placebo group' and 'placebo control': a case study in psychedelic microdosingBalázs Szigeti, David Nutt, Robin Carhart-Harris, et al.
The Journal of Clinical Psychiatry|March 28, 2008
Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depressionMadhukar H Trivedi, Eric Hollander, David Nutt, et al.
Psychopharmacology|January 22, 2003
Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteersCaroline Bell, Sue Wilson, Ann Rich, et al.
Human Psychopharmacology|October 31, 2002
GABAAbenzodiazepine receptor (GBzR) sensitivity: test-retest reliability in normal volunteersJohn Potokar, John Nash, John Sandford, et al.
BMJ Open|September 22, 2020
So near yet so far: why won't the UK prescribe medical cannabis?David Nutt, Steve Bazire, Lawrence D Phillips, et al.
Pageof 18

Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|March 27, 2007
Development of a rational scale to assess the harm of drugs of potential misuseDavid Nutt, Leslie A King, William Saulsbury, et al.
BMJ (Clinical Research Ed.)|October 16, 2024
Should recreational cannabis be legalised in the UK?David Nutt, Lucy Stafford, Robin M Murray, et al.
The European Journal of Neuroscience|June 7, 2016
Introduction to the 2016 Consensus Document on European Brain ResearchMonica Di Luca, Paul Bolam, John Foxe, et al.
Journal of Psychopharmacology (Oxford, England)|January 25, 2013
Generic legislation of new psychoactive drugsJan van Amsterdam, David Nutt, Wim van den Brink
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 22, 2016
Neurochemical binding profiles of novel indole and benzofuran MDMA analoguesJakob A Shimshoni, Ilan Winkler, Ezekiel Golan, et al.
Scientific Reports|July 26, 2023
The difference between 'placebo group' and 'placebo control': a case study in psychedelic microdosingBalázs Szigeti, David Nutt, Robin Carhart-Harris, et al.
The Journal of Clinical Psychiatry|March 28, 2008
Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depressionMadhukar H Trivedi, Eric Hollander, David Nutt, et al.
Psychopharmacology|January 22, 2003
Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteersCaroline Bell, Sue Wilson, Ann Rich, et al.
Human Psychopharmacology|October 31, 2002
GABAAbenzodiazepine receptor (GBzR) sensitivity: test-retest reliability in normal volunteersJohn Potokar, John Nash, John Sandford, et al.
BMJ Open|September 22, 2020
So near yet so far: why won't the UK prescribe medical cannabis?David Nutt, Steve Bazire, Lawrence D Phillips, et al.
Pageof 18